Keyword Connections

targeted therapy

Journals

12

1 Scientific reports

2 Physical chemistry chemical physics : PCCP

3 nanomedicine (london, england)

4 artificial cells, nanomedicine, and biotechnology

5 the journal of pathology

6 digestive and liver disease : official journal of the italian society of gastroenterology and the italian association for the study of the liver

7 thyroid : official journal of the american thyroid association

8 acta medica academica

9 lung cancer (amsterdam, netherlands)

10 Photodiagnosis and photodynamic therapy

11 molecular therapy oncolytics

12 Lung Cancer (Auckland, N.Z.)

Research Groups

0

No Research Group Connected

Bibliographies

62

1 Hypericin and its radio iodinated derivatives - a novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitro.

2 and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide.

3 Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society.

4 Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.

5 Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?

6 targeting hypoxia inducible factors-1α as a novel therapy in fibrosis

7 adenosquamous carcinoma of the lung

8 current strategies and future perspectives for precision medicine in pancreatic cancer

9 editorial: update on the treatment of metastatic non-small cell lung cancer (nsclc) in new era of personalised medicine

10 surgical management of advanced and metastatic renal cell carcinoma: a multidisciplinary approach

11 use of a combination of Аvastin and low-dose interferon- α in the first-line treatment of metastatic renal-cell cancer

12 nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments

13 an expression of concern on discoidin domain receptors: potential actors and targets in cancer

14 current idea of an algorithm for drug treatment and optimal succession of using targeted drugs

15 emerging treatments for her2-positive early-stage breast cancer: focus on neratinib

16 the tip of the iceberg: clinical implications of genomic sequencing projects in head and neck cancer

17 systemic therapy of cancer: facts and expectations

18 targeted and effective photodynamic therapy for cancer using functionalized nanomaterials

19 molecular differences in the kras gene mutation between a primary tumor and related metastatic sites – case report and a literature review

20 omics and immunologic approaches to optimizing cure rates in her2-positive breast carcinomas.

21 analysis of the efficacy and survival of third-line treatment  in advanced non-small cell lung cancer

22 first-line treatment in egfr mutant non-small cell lung cancer: is there a best option?

23 hepatocellular carcinoma: past and future of molecular target therapy

24 Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the Gene Have Durable Responses to ALK Kinase Inhibitors.

25 Enrichment experiment of ventilation air methane (0.5%) by the mechanical tower.

26 Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine

27 SMARCA4-deficient NSCLC treated with first-line tislelizumab and fruquintinib achieved remarkable tumor regression: case report and literature review.

28 Mechanistic Insights and Therapeutic Potentials of Ubiquitin-Proteasome System in Non-Small Cell Lung Cancer.

29 Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry.

30 Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell Carcinoma.

31 Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

32 Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era

33 Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy

34 Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

35 Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: Response, Progression, and Pseudoprogression.

36 Interview with Alena Ledeneva: To control a level of informality you need the targeted therapy of informal practices

37 Reduction of Global H3K27me Enhances HER2/ErbB2 Targeted Therapy.

38 AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.

39 A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy

40 Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?

41 Optically Active Nanomaterials for Bioimaging and Targeted Therapy

42 Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study (Signal Transduction and Targeted Therapy, (2020), 5, 1, (33), 10.1038/s41392-020-0148-4)

43 Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy

44 Management of Nonsevere Pneumonia in Military Trainees with the Urinary Antigen Test for Streptococcus pneumoniae: An Innovative Approach to Targeted Therapy

45 molecular targeted therapy in advanced renal cell carcinoma: a review of its recent past and a glimpse into the near future

46 targeted therapy for metastatic renal cell carcinoma

47 is the improved efficacy of trastuzumab and lapatinib combination worth the added toxicity? a discussion of current evidence, recommendations, and ethical issues regarding dual her2-targeted therapy

48 ror1 and ror2 in human malignancies: potentials for targeted therapy

49 recent advances in treatment of childhood cancer : role of targeted therapy

50 clinical application of liquid biopsy in targeted therapy of metastatic colorectal cancer

51 shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer

52 targeted therapy- vemurafinib in braf v600e positive langerhan cell histiocytosis

53 effects of rankl-targeted therapy in immunity and cancer

54 kshv targeted therapy: an update on inhibitors of viral lytic replication

55 holding the inflammatory system in check: tlrs and their targeted therapy in asthma

56 research advances in molecular targeted therapy for advanced biliary tract cancer

57 use of magnetic nanoparticles as targeted therapy: theranostic approach to treat and diagnose cancer

58 targeted therapy in gastrointestinal malignancies

59 Targeted therapy in patients with PIK3CA-related overgrowth syndrome - Nature

60 Targeted therapy in patients with PIK3CA-related overgrowth syndrome

61 Drug delivery approaches for HuR-targeted therapy for lung cancer.

62 Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza